Newsroom

Newsroom

Outcomes in oncogenic-addicted advanced NSClC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay

Literature
Read More

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay

Literature
Read More

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Press Release
Read More

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference

Press Release
Read More

Variant IGH FISH Patterns in Plasma Cell Myeloma

Literature
Read More

Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC)

Literature
Read More

Role of epigenetic regulators in Single Base Substitution patterns in AML

Literature
Read More

STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients